Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Leukemia, B-Cell × acalabrutinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 3 Lymphoma, Mantle-Cell 2 Lymphoma, Non-Hodgkin 1 Leukemia, B-Cell 1 Leukemia 1

Interventions

venetoclax 1 obinutuzumab 1 acalabrutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03836261 2024-12-27

AMPLIFY

Acerta Pharma BV

Phase 3 Active not recruiting

984 enrolled 1 FDA

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡